MGC70857 Inhibitors
MGC70857, also known as C6orf211, is a gene annotated with "MGC" (Mammalian Gene Collection), MGC70857 was identified through genome sequencing projects aimed at providing a complete set of full-length (open reading frame) cDNA clones. The MGC Program has been an invaluable resource for the genomics and molecular biology community, as it facilitates the study of gene function by providing the necessary templates for protein expression, functional analysis, and other molecular investigations.
The protein encoded by MGC70857 is presumed to be involved in cellular processes due to its conserved structure and expression patterns, but specific roles remain to be elucidated. It is part of the broader landscape of the human proteome that encompasses proteins with unknown functions, often referred to as "dark matter" of the human genome. This term signifies the substantial portion of the genome that produces RNA transcripts and presumably proteins, yet their functions, interactions, and regulatory mechanisms are not well understood.
SEE ALSO...
Items 1 to 10 of 19 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent, broad-spectrum inhibitor of protein kinases, potentially affecting proteins like MGC70857 indirectly through kinase pathways. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which can indirectly influence various proteins including MGC70870. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which could affect signaling pathways potentially linked to MGC70870. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that might influence pathways indirectly associated with MGC70857. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, possibly impacting cellular processes related to MGC70857. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
P38 MAP kinase inhibitor, potentially altering pathways indirectly related to MGC70857. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
As a glucocorticoid, dexamethasone can regulate gene expression and may indirectly influence MGC70870. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium influences several signaling pathways, including Wnt signaling, which might impact proteins like MGC70870. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, which may influence pathways indirectly associated with MGC70857. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor, potentially affecting pathways related to MGC70857. | ||||||